Adjuvant for vaccine immunotherapy of cancer--focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunity (Q26782131)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Adjuvant for vaccine immunotherapy of cancer--focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunity |
scientific article |
Statements
Adjuvant for vaccine immunotherapy of cancer--focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunity (English)
2 references
Tsukasa Seya
Yohei Takeda
Megumi Tatematsu
Ken Takashima
Misako Matsumoto
18 November 2015
1 December 2015
3 references
9 September 2020
11 December 2020
23 December 2020
10 references
20 June 2019
25 June 2019
31 July 2019
3 August 2019
4 August 2019
15 December 2019
9 September 2020
11 December 2020
23 December 2020
9 references
20 June 2019
25 June 2019
31 July 2019
3 August 2019
4 August 2019
15 December 2019
9 September 2020
11 December 2020
23 December 2020
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
2 references
2 references
2 references